Article info
Clinical ethics
Neuromuscular blockers—a means of palliation?
- Correspondence to: Dr L Hawryluck, Ian Anderson Continuing Education Program in End of Life Care, University Health Network, University of Toronto, Canada; laura.hawryluck{at}utoronto.ca
Citation
Neuromuscular blockers—a means of palliation?
Publication history
- Accepted January 18, 2002
- Revised January 17, 2002
- First published June 1, 2002.
Online issue publication
June 01, 2002
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by the Journal of Medical Ethics
Other content recommended for you
- Terminal sedation and the “imminence condition”
- The agony of agonal respiration: is the last gasp necessary?
- Analgesics, sedatives and neuromuscular blockers as part of end-of-life decisions in Dutch NICUs
- Response to Ronald M Perkin and David B Resnik: The agony of trying to match sanctity of life and patient-centred medical care
- Weakening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
- Strengthening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
- A response to critics: weakening the ethical distinction between euthanasia, palliative opioid use and palliative sedation
- Does the doctrine of double effect apply to the prescription of barbiturates? Syme vs the Medical Board of Australia
- Expanded terminal sedation in end-of-life care
- Ethical end-of-life palliative care: response to Riisfeldt